Qualigen Therapeutics (QLGN) has entered into definitive securities purchase agreements with several institutional and accredited investors ...

(NASDAQ: OMCL) (“Omnicell”) today announced that it intends to offer, subject to market conditions and other factors, $150.0 ...

Goldgroup Mining (TSE:GGA) has released an update.Don't Miss our Black Friday Offers:Discover the latest stocks recommended by top Wall Street ...

The flow-through component of the Private Placement will consist of up to 10.7 million FT Shares at a price of $0.14 cents per FT Share, for aggregate gross proceeds of up to $1,500,000 (the " FT ...

Aclaris Therapeutics ($ACRS) stock rose more than 46% on Tuesday after the clinical-stage biopharmaceutical company entered ...

The Quarterly Repayment will be made on 13 December 2024 and will be settled in its entirety in cash through the proceeds from Private Placement. Accordingly, the result of the Private Placement and ...

Cerro de Pasco Resources Inc. (CSE: CDPR) (OTCQB: GPPRF) (FRA: N8HP) (“CDPR” or the “Corporation”) announces that is has filed an amended and restated offering document dated November 19, 2024 (the “A ...

Houston-based LandBridge Co. LLC (NYSE: LB), which launched its initial public offering earlier this year, is acquiring 46,000 more acres in the Delaware Basin. LandBridge will buy the land, known as ...

KDC REIT's manager plans around $1 billion in EFR comprising $600 million in placement, $300 million in preferential offering and $85 million for sponsor subscription.

Pantheon Resources (GB:PANR) has released an update. Pantheon Resources has issued over 9 million new shares through a private placement to raise ...

News on Inhibikase's promising treatments for PAH and Parkinson's Disease, supported by FDA approval and substantial funding.

The Bangladesh Securities and Exchange Commission (BSEC) yesterday approved the issuance of subordinated bonds totalling Tk2,000 crore by five banks to strengthen their Tier-2 capital base. All the ...